info@synchemia.com | sales@synchemia.com 
9766925136 
N-Nitroso Edoxaban Desmethyl Impurity
_1.png)
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Edoxaban is used to prevent stroke and blood clots in patients with a certain heart rhythm problem (eg, nonvalvular atrial fibrillation). Edoxaban is also used to treat deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs . N-Nitroso Edoxaban Desmethyl Impurity is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Edoxaban Desmethyl Impurity chemically represented as N1-(5-Chloropyridin-2-yl)-N2-((1S,2R,4S)-4-(dimethylcarbamoyl)-2-(5- nitroso-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2- carboxamido)cyclohexyl)oxalamid .Synchemia is the leading manufacturing and exporter of N-Nitroso Edoxaban Desmethyl Impurity. We supply N-Nitroso Edoxaban Desmethyl Impurity with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N0143380 |
| CAS No | NA |
| Mol.F. | C23H31N7O6S |
| Mol.Wt. | 533.60 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143381 |
| CAS No | NA |
| Mol.F. | C21H27N7O5S |
| Mol.Wt. | 489.55 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143382 |
| CAS No | NA |
| Mol.F. | C25H33N7O4 |
| Mol.Wt. | 495.58 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143383 |
| CAS No | NA |
| Mol.F. | C18H19N5O5 |
| Mol.Wt. | 385.38 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143384 |
| CAS No | NA |
| Mol.F. | C23H31N7O6S |
| Mol.Wt. | 533.60 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143385 |
| CAS No | NA |
| Mol.F. | C21H25N7O6S |
| Mol.Wt. | 503.53 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143386 |
| CAS No | NA |
| Mol.F. | C17H17N5O5 |
| Mol.Wt. | 371.35 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143387 |
| CAS No | NA |
| Mol.F. | C23H29N7O7S |
| Mol.Wt. | 547.59 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143388 |
| CAS No | NA |
| Mol.F. | C21H25N7O8S |
| Mol.Wt. | 535.53 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143389 |
| CAS No | NA |
| Mol.F. | C17H21N5O4 |
| Mol.Wt. | 359.39 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143390 |
| CAS No | NA |
| Mol.F. | C25H33N7O2S2 |
| Mol.Wt. | 527.71 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143391 |
| CAS No | NA |
| Mol.F. | C6H13N3O |
| Mol.Wt. | 143.19 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143392 |
| CAS No | NA |
| Mol.F. | C16H16N4O4 |
| Mol.Wt. | 367.33 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143393 |
| CAS No | NA |
| Mol.F. | C31H45N3O8 |
| Mol.Wt. | 587.7 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143394 |
| CAS No | 23595-00-8 |
| Mol.F. | C14H9F3N2O3 |
| Mol.Wt. | 310.2 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143395 |
| CAS No | NA |
| Mol.F. | C18H29N3O4 |
| Mol.Wt. | 351.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
